Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Melanoma × Data Collection × Clear all

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Papillomavirus Infections 7 Uterine Cervical Neoplasms 4 Neuroendocrine Tumors 4 Neoplasms 4 Autoimmune Diseases 3 Ovarian Neoplasms 2 Myasthenia Gravis 2 Mesothelioma, Malignant 2 Venous Thrombosis 1 Venous Thromboembolism 1 Thyroid Diseases 1 Thrombosis 1 Retinal Telangiectasis 1 Renal Insufficiency 1 Recurrence 1 Prostatic Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Mesothelioma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphohistiocytosis, Hemophagocytic 1 Lung Neoplasms 1 Leukemia, Hairy Cell 1 Hemorrhage 1 Hematologic Neoplasms 1 Fanconi Anemia, Complementation Group D1 1 Desmoid Tumors 1 Cysts 1 Colonic Neoplasms 1

Interventions

Ipilimumab 96 pembrolizumab 80 aldesleukin 77 Nivolumab 75 Interleukin-2 46 Cyclophosphamide 46 Dacarbazine 44 trametinib 32 Vemurafenib 32 incomplete Freund's adjuvant 31 fludarabine phosphate 30 Temozolomide 30 sargramostim 28 dabrafenib 26 Bevacizumab 22 fludarabine 20 Paclitaxel 19 MART-1 Antigen 18 Cisplatin 18 montanide ISA 51 17 Interferon-alpha 17 Sorafenib 16 Carboplatin 16 Introns 15 Granulocyte-Macrophage Colony-Stimulating Factor 15 Filgrastim 14 tremelimumab 13 atezolizumab 13 Radiotherapy 13 Radiosurgery 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02883933 2016-08-30

head neck-mel

CHU de Reims

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡